Delivery Order SPE2DB20D1100-SPE2DB25FC0C0
Award Date
4/29/25
Potential Completion Date
5/20/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,994.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of January 7, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product. The contract has a ceiling value of $13,491.97 and runs through May 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ03N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,121.56 Firm Fixed Price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,560.77, is for the delivery of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs...
This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Amerisourcebergen Corporation. The $37,682.31 contract is for the supply of 4,564,169,037 tablets of the oncology drug LUMAKRAS (325 mg) to support military medical treatment programs and facilities. The award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FDUR8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $12,560.77 and a completion date of February 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product, with a ceiling value of $13,304.34 and a period of performance through October 19, 2023. This contract is not set-aside and was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This federal contract award is a delivery order valued at $12,446.16, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of LAZCLUZE 240 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 11, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,446.16, is for the delivery of LAZCLUZE 240 MG TABLET 30S, a medical product, and has an ultimate completion date of April 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation....
This federal contract award, identified as SPE2DX15D1053|SPE2DX25F6MRC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,446.16 firm fixed-price delivery order is for the supply of LAZCLUZE 240 MG TABLET 30S, a pharmaceutical product, with a performance period ending on May 16, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999.00...